Cardio Diagnostics Holdings, Inc. (CDIO)
1.83
-0.14
(-7.11%)
USD |
NASDAQ |
May 05, 16:00
1.86
+0.03
(+1.64%)
After-Hours: 20:00
Cardio Diagnostics Holdings EPS Diluted (Quarterly) : -0.8025 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.465M |
| Revenue (Quarterly) | 0.0036M |
| Total Expenses (Quarterly) | 1.469M |
| Enterprise Value | 1.001M |
| Gross Profit Margin (Quarterly) | -4.33K% |
| Profit Margin (Quarterly) | -40.71K% |
| Earnings Yield | -203.0% |
| Normalized Earnings Yield | -203.03 |